Diabetes & Endocrinology Perspective

• Aspirin in Primary Prevention of CVD: Rational Use   The aspirin question returns as the balance of benefits vs harms for some patient groups is reassessed.
  Medscape Ob/Gyn, May 04, 2022
• Key Points From the New Heart Failure Guidelines   Dr Ileana Piña discusses the 2022 AHA/ACC/HFSA heart failure guidelines and how they compare with the European guidelines and recent data on heart failure.
  theheart.org on Medscape, May 04, 2022
• Paxlovid Is Here: A Pharmacist's Prescribing Pearls An effective oral medication for COVID-19 is now available. Michael Ganio, PharmD, offers tips on how to prescribe it safely, where to find it in your area, and how it works with the Test to Treat program.
  Medscape Family Medicine, May 03, 2022
• COVID-19 Vaccine Effectiveness CDC answers questions about how effective vaccines are against preventing serious illness with newer COVID variants.
  CDC Expert Commentary, May 03, 2022
• What Is the Glycemic Risk Index and Why Do We Need It?   Dr Anne Peters discusses the development of the glycemic risk index, a new continuous glucose monitoring measure.
  Medscape Diabetes & Endocrinology, May 02, 2022
• It's Time to Shame the Fat Shamers People with obesity are more likely to receive substandard treatment from their healthcare providers. Is bias toward people with obesity affecting your treatment of these patients?
  Medscape Diabetes & Endocrinology, April 28, 2022
• Cure, Prevent, or Manage All Disease: The Chan Zuckerberg Initiative's Bold Plan Is Already Working   Dr Eric Topol sits down with Mark Zuckerberg and Priscilla Chan to talk about the next phase of their ambitious Chan Zuckerberg Initiative.
  Medscape, April 28, 2022
• American College of Cardiology 2022: Reflections on Lipid Management   Amun Saeed, MD, highlights the potential therapeutic advances presented by the results of three studies: APOLLO, PACMAN-AMI, and TRANSLATE-TIMI 70.
  Medscape, April 27, 2022
• How Gender-Affirming Care Is Provided to Adolescents in the US In a sample of trans adults (n = 27,715), 10% started to realize they were transgender at age 5 or younger, 16% between ages 6 and 10, 28% between 11 and 15, 29% between 16 and 20, and 18% at age 21 or older.
  Medscape Pediatrics, April 25, 2022
• Diabetes and Heart Disease Highlights From ACC 2022   Dr Martha Gulati shares key reports from ACC 2022, including updates on SGLT2 inhibitors from the SCORED trial, chronic hypertension in pregnancy, and heart-healthy diet education in supermarkets.
  Medscape, April 25, 2022
• Top Abstracts in Atherosclerosis and Lipid Management From ACC 2022   Key data on atherosclerosis and lipids from ACC 2022 include PACMAN-AMI results with alirocumab, a new look at waist circumference in REDUCE-IT, and a subgroup analysis of SCORED with sotagliflozin.
  Medscape, April 25, 2022
• Breast Anatomy and Augmentation in Transfeminine Individuals There is an increasing number of transgender women seeking breast augmentation – with approximately 60%-70% of patients having desired or undergone the procedure.
  Medscape Ob/Gyn, April 22, 2022
• Infographic: Physician Incomes Gain, Pay Gaps Remain The Medscape Physician Compensation Report 2022 infographic shows growth in physician income, specialties with biggest pay gains, and pay disparities between men and women and between ethnic groups.
  Medscape, April 22, 2022
• Trans Women in Female Sports: A Sports Scientist's Take Swimmer Lia Thomas put trans women's participation in female sports back in the headlines. Exercise physiologist Ross Tucker discusses the science and the colliding rights of fairness and inclusion.
  Medscape Orthopedics, April 21, 2022
• Graves Disease, Thyroid Eye Disease, and COVID-19 Is there a link between COVID-19 cases or vaccinations and the increased reports of thyroid autoimmunity and its complications? Drs McLeod and Balcerek attempt to answer this question.
  American Thyroid Association, April 21, 2022
• Animal Reservoirs, Immunocompromised Hosts: COVID Dangers Ahead   Stanford's Benjamin Pinsky on the potential for even more transmissible and pathogenic versions of the SARS-CoV-2 virus to arise.
  Medscape, April 21, 2022
• Long-Term Anti-VEGF Delivery System Draws Closer to Primetime The Port Delivery System is a refillable intravitreal implant designed to deliver a continuous supply of ranibizumab into the vitreous. Is it as good as intravitreal ranibizumab injections?
  Medscape Ophthalmology, April 20, 2022
• Cancer Groundshot: From Blog Post to ASCO Session Bishal Gyawali, MD, PhD, looks at the rise of the cancer groundshot.
  Medscape Oncology, April 20, 2022
• Type 2 Diabetes With ASCVD   Experts in endocrinology and cardiology evaluate a patient with troubling risk factors for cardiovascular disease and discuss the potential benefits of new therapies and lifestyle modifications.
  Medscape, April 19, 2022
• Battling Obesity by Breaking Down Barriers Two primary care physicians detail their experiences in treating those with obesity through a community-based dedicated weight clinic after receiving their obesity medicine certification.
  Medscape Diabetes & Endocrinology, April 19, 2022